Stay Up to Date
Breaking News,
Updates, & More
Click Here to
Subscribe

Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419

Audiocasts - Head and Neck Cancer
Carryn Anderson, MD

Carryn Anderson, MD, discusses the clinical significance of her research on, “Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419.”

Related Items
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
Corbin Davis
TOP - August 2018, Vol 11, No 2 published on August 3, 2018 in Head and Neck Cancer
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Eric Allan, MD
Audiocasts published on July 22, 2016 in Head and Neck Cancer
Low-Level Laser Therapy Reduces Pain in Patients with Head and Neck Cancer
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Head and Neck Cancer
Prophylactic Gabapentin Linked to Weight Loss, Narcotic Dependency
Meg Barbor, MPH
TOP - May 2016, Vol 9, No 2 published on May 13, 2016 in Conference Correspondent, Head and Neck Cancer
Infrastructure Issues in the US Drug Supply: Where Did the Drugs Go?
Timothy G. Tyler, PharmD, FCSHP
Web Exclusives published on November 29, 2011 in Head and Neck Cancer
Biopsy of Sentinel Lymph Node Considered Safe and Effective in Head and Neck Melanomas
TON - Daily published on August 8, 2011 in Head and Neck Cancer
Concurrent Chemotherapy with Reirradiation for Head and Neck Cancer
TOP - Daily published on June 17, 2011 in Head and Neck Cancer
Concurrent Chemotherapy with Reirradiation for Head and Neck Cancer
TON - Daily published on June 17, 2011 in Head and Neck Cancer
Last modified: July 12, 2016